United States · Platforms & data · MarketBeat
Acrivon Therapeutics (NASDAQ:ACRV) Stock Keeps "Market Outperform" Rating at Citizens Jmp

Detailed summary
Citizens Jmp reissued a "market outperform" rating on shares of Acrivon Therapeutics in a report on Tuesday.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)



